Dumb Blonde” podcast host Bunnie XO said she’s already lost more than a pound — but said she's “microdosing” tirzepatide ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

Paying $1,200 a month for the name-brand drug Zepbound wasn’t sustainable, and it was becoming impossible to find, she said. And she’s not alone. Readdy turned to online communities where ...

Compounding pharmacies have used a legal provision that allows them to make knockoff versions of Lilly’s Zepbound and Mounjaro while they are in a shortage. While Lilly has raised questions ...

His downgrade comes after Eli Lilly (LLY) said in June that the injectable marketed as Zepbound for obesity met the main goals in a Phase 3 program for adults with obesity and obstructive sleep apnea.

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They're in short supply, and often too expensive to afford without insurance coverage. Advertisement ...

It’s a field that’s already undergoing a revolution, with millions of people across the US now using semaglutide and tirzepatide, sold as Wegovy and Zepbound for weight loss (and for diabetes ...

Note: The study results for Mounjaro or Zepbound didn’t state whether the burping reported was specifically sulfur burps. But because of how the drugs work, sulfur burps can occur. Limiting ...